Generating real-world external comparators (rwECs) for randomized clinical trials (RCTs) in metastatic breast cancer (mBC) using electronic health records (EHRs) Published December 2021 Citation Amiri-Kordestani, L, Gao, X, Baxi, SS, Bloomquist, E, Bryan, J, Howie, L, Keane, C, Kluetz, P, Osgood, C, Paliwal, P, Rivera, DR, Roose, JP, Schneider, J, Ssingh, H, Tang, S, Zhang, L, Beaver, J. . SABCS. . https://www.sabcs.org/Program/Poster-Sessions/Poster-Session-2 Authors:Amiri-Kordestani, L, Gao, X, Baxi, SS, Bloomquist, E, Bryan, J, Howie, L, Keane, C, Kluetz, P, Osgood, C, Paliwal, P, Rivera, DR, Roose, JP, Schneider, J, Ssingh, H, Tang, S, Zhang, L, Beaver, J Sources:San Antonio Breast Cancer Symposium Share Posted inPublicationsMethodologyComparative effectivenessMetastatic breast cancer More publicationsESMO OpenSeptember 2025Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practiceRugo H, Layman R, Lynce F, et al.Publication summaryPublicationsComparative effectivenessMetastatic breast cancerBreast cancerMedical Decision MakingApril 2026Using regression discontinuity in time to strengthen real-world evidence: a case study in lung cancerChen NC, Zemplenyi AT, Adamson B, et al.Publication summaryPublicationsMethodologyNon-small cell lung cancerISPORApril 2026Evaluating model performance for between-country survival transportabilityAli MS, Pittell H, Horne E, Mpofu P, Zhang Q, Adamson B, et al.Publication summaryPublicationsMethodologyMultiple myeloma